41.300
−0,24%
2026-10-19
Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +22.2% | +7.7% | 2 / 3 | -0.3% | +2.43 pp | +12.01 pp | +15.8% | 0.12 | 13.25 | 6.324 | −0,3% | 3.358 | +28,9% | 13.25 | 22.09 | −40,0% |
| Pts | 4 | 0 | 8 | 0 | 8 | 12 | 4 | 12 | 12 | |||||||
Valuation annotation:Price: 41.300 (close price on 2026-10-19)EPS (TTM): 3.117
Financial charts
1.Revenue & growth
VND bn6.324Q2/26
1.Revenue & growth
VND bn6.324Q2/26
2.Profit & growth
VND bn2.703Q2/26
3.Profit mix (Penman)
VND bn16.630Q2/26
4.Margins & cost structure
%59.7%Q2/26
5.Returns & cash cycle
% · days17.8%Q2/26
6.Earnings quality & cash
VND bn13.582Q2/26
7.Asset structure
VND bn93.954Q2/26
8.Funding & debt health
VND bn · times93.954Q2/26
9.Revenue backlog
VND bn19,1Q2/26
10.Valuation
times · %13,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %755Q2/26
Adjusted EPS growth, latest quarter
22.2%
Average adjusted EPS growth, 3 quarters
7.7%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26